• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2开放阅读框3a在口腔和肺上皮细胞中诱导[具体内容缺失]的表达,而食品补充剂Vita Deyun可减弱这种效应。

Severe acute respiratory syndrome coronavirus 2 ORF3a induces the expression of in oral and pulmonary epithelial cells and the food supplement Vita Deyun diminishes this effect.

作者信息

Aguilar-Lemarroy Adriana, López-Uribe Apolinar, Sánchez-Corona José, Jave-Suárez Luis Felipe

机构信息

Division of Immunology, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, Jalisco 44340, Mexico.

出版信息

Exp Ther Med. 2021 May;21(5):485. doi: 10.3892/etm.2021.9916. Epub 2021 Mar 16.

DOI:10.3892/etm.2021.9916
PMID:33790994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8005676/
Abstract

The coronavirus disease 2019 (COVID-19) pandemic has become a serious global health problem and numerous studies are currently being conducted to improve understanding of the components of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, as well as to identify solutions that mitigate the effects of COVID-19 symptoms. The nutritional supplement Vita Deyun is composed of silymarin, glutathione, vitamin C and selenium. Studies of its individual components have demonstrated their benefits as anti-inflammatory agents, antioxidants and enhancers of the immune response. Therefore, the present study aimed to evaluate the effects of Vita Deyun on the expression of angiotensin-converting enzyme 2 () in diverse cell lines, as well as in the presence or absence of the SARS-CoV-2 open reading frame (ORF)3a protein. Through reverse transcription-quantitative PCR, the use of viral particles containing SARS-CoV-2 ORF3a and bioinformatics analysis via the National Center for Biotechnology Information databases, was determined to be highly expressed in oral and skin epithelial cells, with a lower expression observed in lung cells. Notably, the expression of SARS-CoV-2 ORF3a increased the level of expression and Vita Deyun treatment diminished this effect. In addition, Vita Deyun treatment markedly decreased interleukin-18 mRNA levels. The combination of phytonutrients in Vita Deyun may help to boost the immune system and could reduce the effects of COVID-19. Ongoing clinical studies are required to provide evidence of the efficacy of Vita Deyun.

摘要

2019年冠状病毒病(COVID-19)大流行已成为一个严重的全球健康问题,目前正在进行大量研究,以增进对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒成分的了解,并确定减轻COVID-19症状影响的解决方案。营养补充剂维她德运由水飞蓟宾、谷胱甘肽、维生素C和硒组成。对其单个成分的研究已证明它们作为抗炎剂、抗氧化剂和免疫反应增强剂的益处。因此,本研究旨在评估维她德运对多种细胞系中血管紧张素转换酶2()表达的影响,以及在存在或不存在SARS-CoV-2开放阅读框(ORF)3a蛋白的情况下的影响。通过逆转录定量PCR、使用含有SARS-CoV-2 ORF3a的病毒颗粒以及通过国家生物技术信息中心数据库进行生物信息学分析,确定在口腔和皮肤上皮细胞中高表达,在肺细胞中表达较低。值得注意的是,SARS-CoV-2 ORF3a的表达增加了表达水平,而维她德运处理减弱了这种作用。此外,维她德运处理显著降低了白细胞介素-18 mRNA水平。维她德运中植物营养素的组合可能有助于增强免疫系统,并可能减轻COVID-19的影响。需要进行正在进行的临床研究以提供维她德运疗效的证据。

相似文献

1
Severe acute respiratory syndrome coronavirus 2 ORF3a induces the expression of in oral and pulmonary epithelial cells and the food supplement Vita Deyun diminishes this effect.严重急性呼吸综合征冠状病毒2开放阅读框3a在口腔和肺上皮细胞中诱导[具体内容缺失]的表达,而食品补充剂Vita Deyun可减弱这种效应。
Exp Ther Med. 2021 May;21(5):485. doi: 10.3892/etm.2021.9916. Epub 2021 Mar 16.
2
[ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].[血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂与冠状病毒引起的严重急性呼吸综合征]
G Ital Cardiol (Rome). 2020 May;21(5):321-327. doi: 10.1714/3343.33127.
3
Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.单细胞分析 SARS-CoV-2 受体 ACE2 和刺突蛋白在人心脏中对蛋白酶的预激活表达。
Cardiovasc Res. 2020 Aug 1;116(10):1733-1741. doi: 10.1093/cvr/cvaa191.
4
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.COVID-19 患者的激肽释放酶-激肽系统阻断治疗以预防急性呼吸窘迫综合征。
Elife. 2020 Apr 27;9:e57555. doi: 10.7554/eLife.57555.
5
Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.转录组分析揭示了 SARS-CoV-2 感染人肺细胞的新机制。
Immun Inflamm Dis. 2020 Dec;8(4):753-762. doi: 10.1002/iid3.366. Epub 2020 Oct 30.
6
SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.SARS-CoV-2 策略性地模拟人类 ENaC 的蛋白水解激活。
Elife. 2020 May 26;9:e58603. doi: 10.7554/eLife.58603.
7
Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.严重急性呼吸综合征冠状病毒2的潜在发病机制。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):591-597. doi: 10.11817/j.issn.1672-7347.2020.200299.
8
Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.综合分析健康个体和癌症患者中两种潜在的新型 SARS-CoV-2 进入受体 TMPRSS2 和 IFITM3。
Int J Biol Sci. 2020 Sep 30;16(15):3028-3036. doi: 10.7150/ijbs.51234. eCollection 2020.
9
A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.血管紧张素 II 的升压剂量对 ACE2 及与 SARS-CoV-2 感染相关的其他分子在小鼠体内没有影响。
FASEB J. 2021 Mar;35(3):e21419. doi: 10.1096/fj.202100016R.
10
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎:分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.

引用本文的文献

1
Gene expression profiling of host lipid metabolism in SARS-CoV-2 infected patients: a systematic review and integrated bioinformatics analysis.SARS-CoV-2 感染患者宿主脂质代谢的基因表达谱:系统评价和综合生物信息学分析。
BMC Infect Dis. 2024 Jan 23;24(1):124. doi: 10.1186/s12879-024-08983-0.
2
Characterization of the angiotensin-converting enzyme 2 (ACE2), the main receptor for the SARS-CoV-2 virus.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的主要受体——血管紧张素转换酶2(ACE2)的特征
Am J Clin Exp Immunol. 2023 Jun 15;12(3):24-44. eCollection 2023.
3
Therapeutic potential of curcumin in ARDS and COVID-19.

本文引用的文献

1
Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction.基于人肺干细胞的肺泡球体为研究 SARS-CoV-2 介导的干扰素反应和肺细胞功能障碍提供了新视角。
Cell Stem Cell. 2020 Dec 3;27(6):890-904.e8. doi: 10.1016/j.stem.2020.10.005. Epub 2020 Oct 21.
2
The Emerging Role of Vitamin C in the Prevention and Treatment of COVID-19.维生素 C 在预防和治疗 COVID-19 中的新作用。
Nutrients. 2020 Oct 27;12(11):3286. doi: 10.3390/nu12113286.
3
Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19.
姜黄素在 ARDS 和 COVID-19 中的治疗潜力。
Clin Exp Pharmacol Physiol. 2023 Apr;50(4):267-276. doi: 10.1111/1440-1681.13744. Epub 2023 Jan 10.
4
The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanisms.水飞蓟宾多酚作为辅助治疗 COVID-19 并发症的有利影响:研究证据和潜在机制的综述。
Biomed Pharmacother. 2022 Oct;154:113593. doi: 10.1016/j.biopha.2022.113593. Epub 2022 Aug 22.
5
Silymarin/curcumin loaded albumin nanoparticles coated by chitosan as muco-inhalable delivery system observing anti-inflammatory and anti COVID-19 characterizations in oleic acid triggered lung injury and in vitro COVID-19 experiment.水飞蓟宾/姜黄素负载白蛋白纳米粒经壳聚糖包被作为黏液吸入式递药系统,观察其在油酸诱导的肺损伤和体外 COVID-19 实验中的抗炎和抗 COVID-19 特性。
Int J Biol Macromol. 2022 Feb 15;198:101-110. doi: 10.1016/j.ijbiomac.2021.12.073. Epub 2021 Dec 28.
针对 COVID-19 发病机制的免疫增强、抗氧化和抗炎食品补充剂。
Front Immunol. 2020 Oct 7;11:570122. doi: 10.3389/fimmu.2020.570122. eCollection 2020.
4
Overview of the possible role of vitamin C in management of COVID-19.维生素 C 在 COVID-19 管理中可能作用概述。
Pharmacol Rep. 2020 Dec;72(6):1517-1528. doi: 10.1007/s43440-020-00176-1. Epub 2020 Oct 28.
5
Health Benefits of : Phytochemistry, Pharmacology, and Applications.植物化学、药理学及应用的健康益处。
J Agric Food Chem. 2020 Oct 21;68(42):11644-11664. doi: 10.1021/acs.jafc.0c04791. Epub 2020 Oct 12.
6
Selenium and RNA Virus Interactions: Potential Implications for SARS-CoV-2 Infection (COVID-19).硒与RNA病毒的相互作用:对严重急性呼吸综合征冠状病毒2感染(2019冠状病毒病)的潜在影响
Front Nutr. 2020 Sep 4;7:164. doi: 10.3389/fnut.2020.00164. eCollection 2020.
7
Identification of potential inhibitors of coronavirus hemagglutinin-esterase using molecular docking, molecular dynamics simulation and binding free energy calculation.利用分子对接、分子动力学模拟和结合自由能计算鉴定冠状病毒血凝素酯酶的潜在抑制剂。
Mol Divers. 2021 Feb;25(1):421-433. doi: 10.1007/s11030-020-10135-w. Epub 2020 Sep 29.
8
Glutathione Supplementation as an Adjunctive Therapy in COVID-19.补充谷胱甘肽作为新冠病毒病的辅助治疗方法
Antioxidants (Basel). 2020 Sep 25;9(10):914. doi: 10.3390/antiox9100914.
9
Selenium and selenoproteins in viral infection with potential relevance to COVID-19.硒和含硒蛋白在病毒感染中的作用及其与 COVID-19 的潜在相关性。
Redox Biol. 2020 Oct;37:101715. doi: 10.1016/j.redox.2020.101715. Epub 2020 Sep 10.
10
Understanding Selenium and Glutathione as Antiviral Factors in COVID-19: Does the Viral M Protease Target Host Selenoproteins and Glutathione Synthesis?了解硒和谷胱甘肽作为新冠病毒中的抗病毒因子:病毒M蛋白酶是否靶向宿主硒蛋白和谷胱甘肽合成?
Front Nutr. 2020 Sep 2;7:143. doi: 10.3389/fnut.2020.00143. eCollection 2020.